The VPN, along with an advanced Access Control Device system provided by Securnet, significantly augments the security and efficiency of communications and data access for the
“The Judiciary Police’s commitment to advanced technological solutions is commendable,” said
“The implementation of these security solutions, facilitated by our collaboration with Securnet was pivotal in maintaining the integrity of communications. These technologies play a vital role in safeguarding information systems and operations, which are essential in the fight against sophisticated criminal networks.”
About Securnet (www.securnet.pt)
Founded in 2002 with the mission of putting organizations “Always online, Always Secure”, Securnet has evolved into a complete provider of IT infrastructure solutions and services. The excellence of Securnet solutions and services is widely recognized by customers and manufacturers as generators of value, innovation and competitiveness. Betting on transparent, trustworthy and long-term relationships, supported by an experienced, efficient, specialized and certified technical team, Securnet is a preferred supplier and technological partner of an increasing number of customers across a diverse range of sectors and industries.
About
BIO-key is revolutionizing authentication and cybersecurity with biometric-centric, multi-factor identity and access management (IAM) software securing access for over thirty-five million users. BIO-key allows customers to choose the right authentication factors for diverse use cases, including phoneless, tokenless, and passwordless biometric options. Its hosted or on-premise PortalGuard IAM solution provides cost-effective, easy-to-deploy, convenient, and secure access to computers, information, applications, and high-value transactions.
About the
The Polícia Judiciária (PJ; English:
BIO-key Safe Harbor Statement
All statements contained in this press release other than statements of historical facts are "forward-looking statements" as defined in the Private Securities Litigation Reform Act of 1995 (the "Act"). The words "estimate," "project," "intends," "expects," "anticipates," "believes" and similar expressions are intended to identify forward-looking statements. Such forward-looking statements are made based on management's beliefs, as well as assumptions made by, and information currently available to, management pursuant to the "safe-harbor" provisions of the Act. These statements are not guarantees of future performance or events and are subject to risks and uncertainties that may cause actual results to differ materially from those included within or implied by such forward-looking statements. These risks and uncertainties include, without limitation, our history of losses and limited revenue; our ability to raise additional capital to satisfy working capital needs; our ability to continue as a going concern; our ability to regain compliance with the Nasdaq continued listing standards, market conditions and the impact of the reverse stock split on the trading price of our common stock; our ability to protect our intellectual property; changes in business conditions; changes in our sales strategy and product development plans; changes in the marketplace; continued services of our executive management team; security breaches; competition in the biometric technology industry; market acceptance of biometric products generally and our products under development; our ability to convert sales opportunities to customer contracts; our ability to expand into
Engage with BIO-key | |
Facebook – Corporate: | https://www.facebook.com/BIOkeyInternational/ |
LinkedIn – Corporate: | https://www.linkedin.com/company/bio-key-international |
Twitter – Corporate: | @BIOkeyIntl |
Twitter – Investors: | @BIO_keyIR |
BIO_keyIR |
Investor Contacts
Catalyst IR
BKYI@catalyst-ir.com or 212-924-9800
Source:
2024 GlobeNewswire, Inc., source